On this point, Zhang et al. recently showed the interest of CD3+ and CD8+ cell infiltration scoring in combination with the TNM staging system in HNSCC patients [29], and our group reported that a high stromal FoxP3+ T cell number combined with tumor stage improved prognosis in HNSCC patients [16]. This evidence concerns the gene CD8A and neoplasm.